Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:13 AM
Ignite Modification Date:
2025-12-25 @ 2:13 AM
NCT ID:
NCT03575260
Eligibility Criteria:
Inclusion Criteria:
* Postmenopausal woman, age \> 18 years old
* Diagnosed with ER/PR+，HER2- Metastatic Breast Cancer
* Adjuvant treatment of Non-steroidal Aromatase Inhibitors
* First line of Metastatic Breast Cancer is 500mg Fulvestrant or Exemestane for at least one month, starting from 2014.01.01-2017.06.01
* Available medical history
Exclusion Criteria:
* Incomplete medical history
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT03575260
Study Brief:
Protocol Section:
NCT03575260